151 related articles for article (PubMed ID: 35998145)
1. 13-amino derivatives of dehydrocostus lactone display greatly enhanced selective toxicity against breast cancer cells and improved binding energies to protein kinases in silico.
Kemboi D; Langat MK; Siwe-Noundou X; Tshiwawa T; Krause RWM; Davison C; Smit CJ; de la Mare JA; Tembu VJ
PLoS One; 2022; 17(8):e0271389. PubMed ID: 35998145
[TBL] [Abstract][Full Text] [Related]
2. In vitro cytotoxic effect of stigmasterol derivatives against breast cancer cells.
Dube NP; Tembu VJ; Nyemba GR; Davison C; Rakodi GH; Kemboi D; de la Mare JA; Siwe-Noundou X; Manicum AE
BMC Complement Med Ther; 2023 Sep; 23(1):316. PubMed ID: 37697361
[TBL] [Abstract][Full Text] [Related]
3. Computational and Molecular Docking Studies of New Benzene Sulfonamide Drugs with Anticancer and Antioxidant Effects.
Mohamed HS; Abdelgawad MA; Hegab M; Hamza ZS; Nagdy AM; Ahmed SA; Ahmed OM; Ghoneim MM
Curr Org Synth; 2023; 20(3):339-350. PubMed ID: 36214306
[TBL] [Abstract][Full Text] [Related]
4. Effect of costunolide and dehydrocostus lactone on cell cycle, apoptosis, and ABC transporter expression in human soft tissue sarcoma cells.
Kretschmer N; Rinner B; Stuendl N; Kaltenegger H; Wolf E; Kunert O; Boechzelt H; Leithner A; Bauer R; Lohberger B
Planta Med; 2012 Nov; 78(16):1749-56. PubMed ID: 23047249
[TBL] [Abstract][Full Text] [Related]
5. Novel Hydrazone Derivatives of 3-Bromopyruvate: Synthesis, Evaluation of the Cytotoxic Effects, Molecular Docking and ADME Studies.
Beygi F; Mostoufi A; Mojaddami A
Chem Biodivers; 2022 Jun; 19(6):e202100754. PubMed ID: 35427437
[TBL] [Abstract][Full Text] [Related]
6. The alpha-methylene-gamma-butyrolactone moiety in dehydrocostus lactone is responsible for cytoprotective heme oxygenase-1 expression through activation of the nuclear factor E2-related factor 2 in HepG2 cells.
Jeong GS; Pae HO; Jeong SO; Kim YC; Kwon TO; Lee HS; Kim NS; Park SD; Chung HT
Eur J Pharmacol; 2007 Jun; 565(1-3):37-44. PubMed ID: 17391667
[TBL] [Abstract][Full Text] [Related]
7. Design, Synthesis, In Vitro Anti-cancer Activity, ADMET Profile and Molecular Docking of Novel Triazolo[3,4-a]phthalazine Derivatives Targeting VEGFR-2 Enzyme.
El-Helby AA; Sakr H; Ayyad RRA; El-Adl K; Ali MM; Khedr F
Anticancer Agents Med Chem; 2018; 18(8):1184-1196. PubMed ID: 29651967
[TBL] [Abstract][Full Text] [Related]
8.
Zegheb N; Boubekri C; Lanez T; Lanez E; Küçükkılınç TT; Öz E; Khennoufa A; Khamouli S; Belaidi S
Anticancer Agents Med Chem; 2022; 22(7):1426-1437. PubMed ID: 34170810
[TBL] [Abstract][Full Text] [Related]
9. VEGFR-2 inhibiting effect and molecular modeling of newly synthesized coumarin derivatives as anti-breast cancer agents.
Ahmed EY; Abdel Latif NA; El-Mansy MF; Elserwy WS; Abdelhafez OM
Bioorg Med Chem; 2020 Mar; 28(5):115328. PubMed ID: 31992477
[TBL] [Abstract][Full Text] [Related]
10. Biological Activity, Apoptotic Induction and Cell Cycle Arrest of New Hydrazonoyl Halides Derivatives.
Mohamed MF; Hassaneen HM; Elzayat EM; El-Hallouty SM; El-Manawaty M; Saleh FM; Mohamed Y; El-Zohiry D; Fahmy G; Abdelaal N; Hassanin N; Hossam N
Anticancer Agents Med Chem; 2019; 19(9):1141-1149. PubMed ID: 30843494
[TBL] [Abstract][Full Text] [Related]
11. 16-Membered Macrolide Lactone Derivatives Bearing a Triazole-Functionalized Arm at the Aglycone C13 Position as Antibacterial and Anticancer Agents.
Domagalska J; Janas A; Pyta K; Pecyna P; Ruszkowski P; Celewicz L; Gajecka M; Bartl F; Przybylski P
ChemMedChem; 2016 Sep; 11(17):1886-91. PubMed ID: 27411730
[TBL] [Abstract][Full Text] [Related]
12. Design, Synthesis, In Silico ADMET Studies and Anticancer Activity of Some New Pyrazoline and Benzodioxole Derivatives.
Tok F; Erdoğan Ö; Çevik Ö; Koçyiğit-Kaymakçıoğlu B
Acta Chim Slov; 2022 Jun; 69(2):293-303. PubMed ID: 35861084
[TBL] [Abstract][Full Text] [Related]
13. Molecular docking, QSAR, pharmacophore modeling, and dynamics studies of some chromone derivatives for the discovery of anti-breast cancer agents against hormone-dependent breast cancer.
Arvindekar SA; Mohole S; Patil A; Mane P; Arvindekar A; Mali SN; Thorat B; Rawat R; Sharma S
J Biomol Struct Dyn; 2023; 41(24):14757-14770. PubMed ID: 36995997
[TBL] [Abstract][Full Text] [Related]
14. Structure-activity relationship studies on O-alkylamino-tethered salicylamide derivatives with various amino acid linkers as potent anticancer agents.
Xu J; Kim H; Dong J; Chen H; Xu J; Ma R; Zhou M; Wang T; Shen Q; Zhou J
Eur J Med Chem; 2022 Apr; 234():114229. PubMed ID: 35334447
[TBL] [Abstract][Full Text] [Related]
15. Design and molecular modeling of novel P38α MAPK inhibitors targeting breast cancer, synthesized from oxygen heterocyclic natural compounds.
Abdelhafez OM; Ahmed EY; Abdel Latif NA; Arafa RK; Abd Elmageed ZY; Ali HI
Bioorg Med Chem; 2019 Apr; 27(7):1308-1319. PubMed ID: 30792101
[TBL] [Abstract][Full Text] [Related]
16. Design, synthesis, molecular docking, anticancer evaluations, and in silico pharmacokinetic studies of novel 5-[(4-chloro/2,4-dichloro)benzylidene]thiazolidine-2,4-dione derivatives as VEGFR-2 inhibitors.
El-Adl K; El-Helby AA; Sakr H; Ayyad RR; Mahdy HA; Nasser M; Abulkhair HS; El-Hddad SSA
Arch Pharm (Weinheim); 2021 Feb; 354(2):e2000279. PubMed ID: 33073374
[TBL] [Abstract][Full Text] [Related]
17. Design, synthesis, and molecular docking of novel 2-arylbenzothiazole multiangiokinase inhibitors targeting breast cancer.
Abdel-Mohsen HT; Abd El-Meguid EA; El Kerdawy AM; Mahmoud AEE; Ali MM
Arch Pharm (Weinheim); 2020 Apr; 353(4):e1900340. PubMed ID: 32045054
[TBL] [Abstract][Full Text] [Related]
18. Phytochemicals from
Teclegeorgish ZW; Mokgalaka NS; Kemboi D; Krause RWM; Siwe-Noundou X; Nyemba GR; Davison C; de la Mare JA; Tembu VJ
Plants (Basel); 2024 Jan; 13(2):. PubMed ID: 38276759
[No Abstract] [Full Text] [Related]
19. New thieno[3,2-d]pyrimidine-based derivatives: Design, synthesis and biological evaluation as antiproliferative agents, EGFR and ARO inhibitors inducing apoptosis in breast cancer cells.
Farghaly AM; AboulWafa OM; Baghdadi HH; Abd El Razik HA; Sedra SMY; Shamaa MM
Bioorg Chem; 2021 Oct; 115():105208. PubMed ID: 34365057
[TBL] [Abstract][Full Text] [Related]
20. Curcumin analogue 1,5-bis(4-hydroxy-3-((4-methylpiperazin-1-yl)methyl)phenyl)penta-1,4-dien-3-one mediates growth arrest and apoptosis by targeting the PI3K/AKT/mTOR and PKC-theta signaling pathways in human breast carcinoma cells.
Badr G; Gul HI; Yamali C; Mohamed AAM; Badr BM; Gul M; Abo Markeb A; Abo El-Maali N
Bioorg Chem; 2018 Aug; 78():46-57. PubMed ID: 29533214
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
